An added benefit of sequential stimulated diagnostic radioiodine whole body scans (WBS) and 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) scans in the management of higher-risk differentiated thyroid cancer (DTC)